Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Herceptin|DRUG: Taxol|DRUG: Adriamycin|DRUG: Cytoxan
Sponsor: Harold J. Burstein, MD, PhD
Collaborators: Dana-Farber Cancer Institute|Genentech, Inc.|Bristol-Myers Squibb|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Harvard Vanguard Medical Associates|Brigham and Women's Hospital